TY - JOUR
T1 - Ionizing radiation biomarkers for potential use in epidemiological studies
AU - Pernot, Eileen
AU - Hall, Janet
AU - Baatout, Sarah
AU - Benotmane, Rafi
AU - Blanchardon, Eric
AU - Bouffler, Simon
AU - El Saghire, Houssein
AU - Gomolka, Maria
AU - Guertler, Anne
AU - Harms-Ringdahl, Mats
AU - Jeggo, Penny
AU - Kreuzer, Michaela
AU - Laurier, Dominique
AU - Lindholm, Carita
AU - Mkacher, Radhia
AU - Quintens, Roel
AU - Rothkamm, Kai
AU - Sabatier, Laure
AU - Tapio, Soile
AU - de Vathaire, Florent
AU - Cardis, Elisabeth
A2 - Vanmarcke, Hans
N1 - Score = 10
PY - 2012/10
Y1 - 2012/10
N2 - Ionizing radiation is a known human carcinogen that can induce a variety of biological effects depending on the physical nature, duration, doses and dose-rates of exposure. However, the magnitude of health risks at low doses and dose-rates (below 100 mSv and/or 0.1 mSv min_1) remains controversial due to a lack of direct human evidence. This review summarises the multidisciplinary work to identify the most appropriate biomarkers for use in population studies. In addition to logistical and ethical considerations for conducting large-scale epidemiological studies, we discuss the relevance of their use for assessing the effects of low dose ionizing radiation exposure at the cellular and physiological level. We also propose a temporal classification of biomarkers that may be relevant for molecular epidemiology studies which need to take into account the time elapsed since exposure. Finally, the integration of biology with epidemiology requires careful planning and enhanced discussions between the epidemiology, biology and dosimetry communities in order to determine the most important questions to be addressed in light of pragmatic considerations including the appropriate population to be investigated (occupationally, environmentally or medically exposed), and study design.
AB - Ionizing radiation is a known human carcinogen that can induce a variety of biological effects depending on the physical nature, duration, doses and dose-rates of exposure. However, the magnitude of health risks at low doses and dose-rates (below 100 mSv and/or 0.1 mSv min_1) remains controversial due to a lack of direct human evidence. This review summarises the multidisciplinary work to identify the most appropriate biomarkers for use in population studies. In addition to logistical and ethical considerations for conducting large-scale epidemiological studies, we discuss the relevance of their use for assessing the effects of low dose ionizing radiation exposure at the cellular and physiological level. We also propose a temporal classification of biomarkers that may be relevant for molecular epidemiology studies which need to take into account the time elapsed since exposure. Finally, the integration of biology with epidemiology requires careful planning and enhanced discussions between the epidemiology, biology and dosimetry communities in order to determine the most important questions to be addressed in light of pragmatic considerations including the appropriate population to be investigated (occupationally, environmentally or medically exposed), and study design.
KW - Low dose ionizing radiation
KW - biomarkers
KW - DoReMi
KW - MELODI
KW - molecular epidemiology
UR - http://ecm.sckcen.be/OTCS/llisapi.dll/open/ezp_124146
UR - http://knowledgecentre.sckcen.be/so2/bibref/9519
U2 - 10.1016/j.mrrev.2012.05.003
DO - 10.1016/j.mrrev.2012.05.003
M3 - Article
SN - 1383-5742
VL - 751
SP - 258
EP - 286
JO - Mutation Research/Reviews in Mutation Research
JF - Mutation Research/Reviews in Mutation Research
IS - 2
ER -